Delivery Order SPE2DB22D2206-SPE2DB23FHD60
- Not listed
- This federal contract award, valued at $25,615.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DETROL LA 2 MG CAPSULE 500S, a pharmaceutical product, with a completion date of December 6, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $12,878.43, is for the delivery of Detrol LA 2 mg capsules to support federal healthcare programs. The contract is a firm fixed-price delivery order with an ultimate completion date of November 8, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $27,579.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of DETROL LA 4 MG CAPSULE 90S, a pharmaceutical product. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 28, 2023. The contract was awarded on a full and open competition basis, with no set-aside designation. Amerisourcebergen Drug Corp,...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4560523200 DETROL LA 4 MG CAPSULE 90S. The $4,867.72 firm fixed-price delivery order has an ultimate completion date of April 10, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of DETROL LA 2 MG CAPSULE 90S. The contract, valued at $7,782.19, is a delivery order that runs through August 24, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order with a Firm Fixed Price valued at $48,661.72. The award was made by the Defense Logistics Agency (DLA) and covers the delivery of DETROL LA 4 MG CAPSULE 500S, a pharmaceutical product, with a completion date of April 28, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of DETROL LA 4 MG CAPSULE 500S. The award, valued at $47,672.17, is a firm fixed-price delivery order with a completion date of May 4, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,050.09 firm-fixed-price delivery order is for the supply of DETROL LA 4 MG CAPSULE 90S, a pharmaceutical product. The award has an ultimate completion date of May 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award, valued at $18,869.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Detrol LA 4 mg capsules, a pharmaceutical product, and has an ultimate completion date of April 28, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of DETROL LA 2 MG CAPSULE 500S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $14,926.41 and an ultimate completion date of September 21, 2023. This award is issued as a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FHD60Delivery Order
This federal contract award, valued at $23,790.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DETROL LA 2 MG CAPSULE 90S, a pharmaceutical product. The contract was awarded on May 12, 2023, with an ultimate completion date of May 15, 2023. This is a firm fixed-price delivery order contract, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and other federal healthcare programs. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.8k | 5/12/23 |